Table 3.
Comparison of body mass index and laboratory results between NAFLD and non-NAFLD patients
| Variable (normal range) | Category | Mean±SD | P |
|---|---|---|---|
| BMI (18.5-24.9) | Non-NAFLD | 29.52±15.516 | 0.42 |
| NAFLD | 30.62±8.682 | ||
| Hg (12-15 g/dL) | Non-NAFLD | 12.79±2.633 | 0.032 |
| NAFLD | 13.33±2.149 | ||
| Platelets (150-400 K/uL) | Non-NAFLD | 255.67±122.668 | 0.866 |
| NAFLD | 257.65±102.321 | ||
| Albumin (35-40 g/L) | Non-NAFLD | 34.40±6.178 | 0.065 |
| NAFLD | 35.60±5.886 | ||
| ALT (30-65 U/L) | Non-NAFLD | 50.23±73.671 | 0.041 |
| NAFLD | 61.84±43.498 | ||
| GGT (5-85 U/L) | Non-NAFLD | 80.91±233.541 | 0.747 |
| NAFLD | 85.97±100.361 | ||
| Bilirubin (1-17 umol/L) | Non-NAFLD | 16.45±34.509 | 0.438 |
| NAFLD | 14.15±24.539 | ||
| INR (1.1-1.4 s) | Non-NAFLD | 1.10±0.268 | 0.308 |
| NAFLD | 1.05±0.413 | ||
| CAP | Non-NAFLD | 238.41±66.865 | <0.001 |
| NAFLD | 297.83±60.765 | ||
| Stiffness score kpa | Non-NAFLD | 10.35±11.329 | 0.224 |
| NAFLD | 12.09±13.704 |
Hg – Hemoglobin; ALT – Alanine aminotransferase; INR – International normalize ratio; CAP – Controlled attenuation parameter; NAFLD – Nonalcoholic fatty liver disease; BMI – Body mass index; GGT – Gamma-glutamyltransferase